Closed transaction

Senn Chemicals announces the successful closing of its acquisition by Granules India

Advised by
Client
Counterparty
Deal stage
Closed transaction
Service
Sell
Sector
Healthcare
Market
EMEA
Contact
ubreitenstein@hoffmann-partner.com

Deal details

Senn Chemicals AG (“Senn Chemicals”) announces the closing of the acquisition by Granules Peptides Private Limited, a wholly owned subsidiary of Granules India Limited (“Granules”) today April 10th, 2025. The acquisition enables Senn Chemicals to support its future as a leading peptide manufacturing company.

Already back in February 2025, the Senn Family signed a share purchase agreement to transfer 100% of the shares of Senn Chemicals to Granules.

Since its founding over 60 years ago by Guido Senn, Senn Chemicals has been a private, family-owned Swiss CDMO specialising in peptides. After a careful evaluation of potential ownership transfer options, the family decided to sell the company to Granules, a vertically integrated pharmaceutical company, focused on manufacturing and selling of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs).

The Senn Chemicals brand and its site in Dielsdorf, Switzerland, will operate under Granules’ ownership, with a commitment to maintaining the company’s scientific excellence and customer focus.

The acquisition brings Senn Chemical’s expertise in Liquid-Phase Peptide Synthesis (LPPS) and Solid-Phase Peptide Synthesis (SPPS), along with a strong CDMO business and established customer relationship, including innovators and brand owners across Pharma, Cosmetics, Amino Acid Derivatives (AAD) & theragnostic segments together with Granules’ market presence in India and the USA.

Together with Senn Chemical’s expertise Granules gains the capabilities into high-growth peptide-based therapeutics. The acquisition aligns with Granules’ vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market, including GLP-1 receptor agonists and other next-generation therapeutics. Granules and Senn Chemicals have active in the development of GLP-1 based APIs, and more peptide-based APIs are planned to be developed using Senn Chemical’s R&D capabilities.

The acquisition marks Granules’ foray into CDMO segments, leveraging Senn Chemical’s existing CDMO business and customer relationships, on back of its R&D and manufacturing platform. With this transaction, Granules will leverage Senn Chemical’s European presence and innovation-driven peptide platform to accelerate its CDMO expansion and meet the fast-growing demand for Amino Acid Derivative (AAD), peptide fragments, and peptide-based therapeutics. Senn Chemical’s presence in Europe provides access to a skilled R&D talent pool and regulated market clients, further strengthening Granules’ global footprint.

Hoffmann & Partner (www.hoffmann-partner.com), the Basel-based M&A advisory firm specialising in life sciences, has acted as the exclusive M&A financial advisor in the transaction and advised the shareholders of Senn Chemicals with technical and industrial expertise.

Urs Breitenstein Partner Hoffmann & Partner Dr. Urs Breitenstein is a founding Partner of Hoffman & Partner. View profile

Hoffmann & Partner latest deals

Advisory

houzy and myky join forces under Swiss Digital Home AG.

Where
Switzerland
Year
2026
Sell-side advisory

Willmann GmbH & Co. KG was sold to Albrecht Group GmbH.

Where
Germany
Year
2026
Sell-side advisory

PharmaX Solutions was sold to BioPhorum.

Where
Germany
Year
2026
Sell-side advisory

House of Flexwork was acquired by Synergie Group.

Where
Switzerland
Year
2026

More by Hoffmann & Partner

More deals in Healthcare

Sell-side advisory

Allied Group has acquired majority stake in Tzamal Medical.

Where
Israel
Year
2026
Sell-side advisory

PharmaX Solutions was sold to BioPhorum.

Where
Germany
Year
2026
Sell-side advisory

Nostos Genomics was sold to Limbus Medical Technologies (varvis®).

Where
Germany
Year
2025

More Healthcare

More deals in Europe

Sell-side advisory

Ocean Property Services Group sold to Lomond.

Where
United Kingdom
Year
2026
Advisory

John Henry Group.

Where
United Kingdom
Year
2026
Advisory

houzy and myky join forces under Swiss Digital Home AG.

Where
Switzerland
Year
2026
Sell-side advisory

Fibreactive sold to discoverIE Group plc.

Where
United Kingdom
Year
2026

More Europe

Membership

Gain worldwide reach with CapFive M&A professionals

The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.

Become a member

Get in touch

Find an adviser.

From a first valuation to signed completion, CapFive member firms advise on sell-side, buy-side, corporate finance and debt.

Share what you are planning and we will connect you with an adviser who has done it before, and who can bring in colleagues across borders when the deal needs them.

Contact us